Lemborexant 10mg: Clinical Trials

2 trials of Lemborexant 10mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1
Phase 11Not yet recruiting 1

Follow Lemborexant 10mg: new trials by email Literature Review of Lemborexant 10mg trials Research Report on Lemborexant 10mg

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lemborexant for Cannabis Use Disorder
Lemborexant 10mg, Placebo, Brief Behavioural Intervention - Cannabis Use Disorder
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary282026-11-012026-09-22
Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty Sleeping
Eszopiclone 3 mg, Placebo, Lemborexant 10mg - OSA - Obstructive Sleep Apnea
Phase 2RecruitingFlinders University152025-10-312026-09-02

Conditions studied

Behavior, Addictive (1)  ·  Marijuana Abuse (1)  ·  Sleep Apnea Syndromes (1)  ·  Sleep Apnea, Obstructive (1)

Sponsors

Flinders University (1)  ·  University of Calgary (1)

Countries

Australia (1)  ·  Canada (1)

Top investigators

Danny J Eckert, PhD (1)  ·  David N Crockford, MD (1)  ·  Leah M Mayo, PhD (1)  ·  Stephanie L Borgland, PhD (1)